Detalles de la búsqueda
1.
Association Between Low Trough Levels of Vedolizumab During Induction Therapy for Inflammatory Bowel Diseases and Need for Additional Doses Within 6 Months.
Clin Gastroenterol Hepatol
; 15(11): 1750-1757.e3, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27890854
2.
Soluble Mucosal Addressin Cell Adhesion Molecule 1 and Retinoic Acid are Potential Tools for Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Treated with Vedolizumab: A Proof of Concept Study.
J Crohns Colitis
; 12(9): 1089-1096, 2018 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29860366
Resultados
1 -
2
de 2
1
Próxima >
>>